Sophy Tablet is a revolutionary natural alternative offering the potential benefits of Berberine for PCOS (polycystic ovary syndrome). Sophy has been supported by multiple Clinical trials in the treatment of PCOS. Sophy contains Berberine as Berberine Phytosome, offering new hope and tangible results in the management of PCOS. Berberine, as a multi-target, multi-path plant extract, can interfere with the development of PCOS and related pathological processes from many aspects, with fewer adverse reactions than conventional drugs. Berberine, through its ability to enhance insulin sensitivity, reduce insulin resistance, and regulate blood sugar levels, holds promise in addressing key aspects of PCOS (polycystic ovary syndrome), particularly the imperative need to reduce insulin resistance for symptom relief. Berberine is more effective in increasing SHBG levels and thereby reduces testosterone and LH levels, which is beneficial in reducing symptoms like hirsutism, acne, and obesity. Unlike Inositol and Metformin, Berberine has the unique benefit of improving the lipid profile and modulation of gut microbiota. Sophy addresses these issues by harnessing Berberine’s potential with the innovative Berberine Phytosome that enhances absorption, making Berberine 10 times more bioavailable.